Search results for "Hdl"

showing 10 items of 298 documents

Bassa prevalenza delle LDL aterogene piccole e dense in una popolazione mediterranea

2002

HDL LDL una popolazione mediterranea
researchProduct

Lipid profile during pregnancy in HIV-infected women

2006

Purpose: We investigated the evolution of serum lipid levels in HIV-infected pregnant women and the potential effect of antiretroviral treatment during pregnancy using data from a national surveillance study. Method: Fasting lipid measurements collected during routine care in pregnancy were used, analyzing longitudinal changes and differences in lipid values at each trimester by protease inhibitors (Pls) and stavudine use. Multivariate analyses were used to control for simultaneous factors potentially leading to hyperlipidemia. Study population included 248 women. Results: Lipid values increased progressively and significantly during pregnancy: mean increases between the first and third tri…

HIV InfectionsTriglyceridechemistry.chemical_compoundPregnancyHiv infectedHyperlipidemiaHIV InfectionPharmacology (medical)Pregnancy Complications Infectioustriglyceridesmedicine.diagnostic_testStavudineStavudineHyperlipidemiaInfectious DiseasesTreatment OutcomeItalyPopulation SurveillancePopulation studylipids (amino acids peptides and proteins)FemalePregnancy TrimesterPregnancy TrimesterspregnancyHumanmedicine.drugAdultmedicine.medical_specialtyLogistic Modelprotease inhibitorsHyperlipidemiascholesterol; HIV; pregnancy; protease inhibitors; triglyceridesprotease inhibitorInternal medicinemedicineHumansHIV Protease InhibitorTriglyceridesPregnancyTriglycerideCholesterolbusiness.industryCholesterol HDLcholesterolHIVCholesterol LDLHIV Protease Inhibitorsmedicine.diseaseLipid MetabolismEndocrinologyLogistic ModelschemistryPregnancy Complications InfectiouHIV-1Lipid profilebusiness
researchProduct

An MDE Approach for Rapid Prototyping and Implementation of Dynamic Reconfigurable Systems

2015

This article presents a co-design methodology based on RecoMARTE, an extension to the well-known UML MARTE profile, which is used for the specification and automatic generation of Dynamic and Partially Reconfigurable Systems-on-Chip (DRSoC). This endeavor is part of a larger framework in which Model-Driven Engineering (MDE) techniques are extensively used for modeling and via model transformations, generating executable models, which are exploited by implementation tools to create reconfigurable systems. More specifically, the methodological aspects presented in this article are concerned with expediting the conception and implementation of the hardware platform and the integration of corre…

IP ReuseComputer scienceIP-XACT02 engineering and technologyDiscrete Controller Synthesis020204 information systemsIP-XACTVHDLPartial Reconfiguration0202 electrical engineering electronic engineering information engineeringCAD[ INFO.INFO-ES ] Computer Science [cs]/Embedded SystemsElectrical and Electronic EngineeringField-programmable gate arrayFPGAcomputer.programming_languagebusiness.industrySystem GenerationControl reconfigurationcomputer.file_formatComputer Graphics and Computer-Aided DesignAutomationUML MARTE020202 computer hardware & architectureComputer Science Applications[INFO.INFO-ES] Computer Science [cs]/Embedded SystemsModel Driven EngineeringEmbedded system[INFO.INFO-ES]Computer Science [cs]/Embedded SystemsExecutableModel-driven architecturebusinesscomputer
researchProduct

Dyslipidemia management with medical nutrition therapy: current status and perspectives

2013

In Italy, patients with dyslipidennia account for 15-20% of the adult population with major healthcare and socio-economic impact. According to the ESC/EAS guidelines for the management of dyslipidemias, desirable cholesterol and triglyceride levels can be achieved with a synergy between drug treatment and adequate diet therapy. However, what diets should be adopted? In this review article, different types of dietary treatments are compared, with a special focus on diet education. The new scientific frontier of nutrigenetics is also discussed.

IncidenceCholesterol HDLCholesterol LDLDiet dyslipidemia metabolic syndrome nutrition obesityDiet MediterraneanDietDiet Carbohydrate-RestrictedNutrigenomicsItalyPatient Education as TopicPractice Guidelines as TopicHumansNutrition TherapyDiet Fat-RestrictedLife StyleBiomarkersTriglyceridesDyslipidemias
researchProduct

Clinical indications and proper use of Visceral Adiposity Index.

2013

Index (economics)Endocrinology Diabetes and MetabolismMedicine (miscellaneous)PhysiologyIntra-Abdominal FatTriglycerides bloodBody Mass Indexchemistry.chemical_compoundBody Fat DistributionHumansMedicineTriglyceridesAdiposityBody fat distributionVisceral Adiposity IndexNutrition and DieteticsCholesterolbusiness.industryCholesterol HDLCholesterol LDLModels TheoreticalchemistryWaist CircumferenceCardiology and Cardiovascular MedicinebusinessBody mass index
researchProduct

RELAZIONI TRA PARAMETRI LIPIDICI E MASSA VENTRICOLARE SINISTRA IN SOGGETTI CON IPERTENSIONE ARTERIOSA ESSENZIALE

2014

Dati non univoci sono riportati in letteratura sul ruolo della dislipidemia nello sviluppo dell’ipertrofia ventricolare sinistra. Scopo del nostro studio, è stato quello di valutare le potenziali associazioni dei principali parametri lipidici con la massa ventricolare sinistra (LVM) in pazienti con ipertensione essenziale (EHs). Abbiamo arruolato 724 soggetti con EH (età media 45±12 anni; 63% maschi), senza complicanze cardiovascolari e non trattati con farmaci ipolipemizzanti. In tutti i soggetti dono stati dosati la colesterolemia totale (Tchol), la trigliceridemia (TG) e il colesterolo HDL (HDLc). Il colesterolo LDL (LDLc) è stato stimato con la formula di Friedewald ed è stato calcolato…

Ipertensione arteriosaDislipidemiaMassa ventricolare sinistraTrigliceridemia.HDL colesterolemia
researchProduct

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

2012

BACKGROUND: High plasma HDL cholesterol is associated with reduced risk of myocardial infarction, but whether this association is causal is unclear. Exploiting the fact that genotypes are randomly assigned at meiosis, are independent of non-genetic confounding, and are unmodified by disease processes, mendelian randomisation can be used to test the hypothesis that the association of a plasma biomarker with disease is causal. METHODS: We performed two mendelian randomisation analyses. First, we used as an instrument a single nucleotide polymorphism (SNP) in the endothelial lipase gene (LIPG Asn396Ser) and tested this SNP in 20 studies (20,913 myocardial infarction cases, 95,407 controls). Se…

LOCIMyocardial Infarction030204 cardiovascular system & hematologychemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinGene Frequencyplasma HDL cholesterol ; mendelian randomisation ; MIHDL cholesterolsingle nucleotide polymorphismRisk FactorsGENETIC-VARIANTSARTERY-DISEASEProspective StudiesMyocardial infarction0303 health sciencesHDL cholesterol; myocardial infarction; single nucleotide polymorphismISCHEMIC CARDIOVASCULAR-DISEASEGeneral Medicine3. Good healthCardiologylipids (amino acids peptides and proteins)medicine.medical_specialtyDalcetrapibSingle-nucleotide polymorphismPolymorphism Single Nucleotide03 medical and health sciencesInternal medicinemedicineHumansCORONARY-HEART-DISEASEGenetic Predisposition to DiseaseMETAANALYSIS030304 developmental biologyBLOOD CHOLESTEROLbusiness.industryCholesterolCholesterol HDLCase-control studyCholesterol LDLLipaseOdds ratioMendelian Randomization Analysismedicine.diseaseENDOTHELIAL LIPASEATHEROSCLEROSISchemistryCase-Control StudiesbusinessHIGH-DENSITY-LIPOPROTEINBiomarkersEvacetrapibThe Lancet
researchProduct

Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria

1999

Leptin levels are elevated in end-stage renal disease, suggesting an impairment of renal leptin degradation. The present study aimed to determine whether leptin levels are also elevated in patients with earlier stages of renal disease, ie, microalbuminuric and macroalbuminuric nephropathy. A total of 60 subjects were assigned to two study groups. Group A contained 10 type 2 diabetics with macroalbuminuria, 10 type 2 diabetics with normoalbuminuria, and 10 healthy control subjects. Group B contained 10 type 2 diabetics with microalbuminuria, 10 type 2 diabetics with normoalbuminuria, and 10 healthy controls. The subgroups of both study groups were matched for sex and body fatness. In group A…

LeptinMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismRenal functionNephropathyEndocrinologyDiabetic NeuropathiesReference ValuesInternal medicineDiabetes mellitusmedicineAlbuminuriaHumansDiabetic NephropathiesTriglyceridesAgedDiabetic RetinopathyProteinuriabusiness.industryLeptinCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseCholesterolEndocrinologyAdipose TissueDiabetes Mellitus Type 2CreatinineHypertensionAlbuminuriaFemaleMicroalbuminuriamedicine.symptombusinessKidney diseaseMetabolism
researchProduct

Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study

2017

Background & Aims: Metabolic syndrome (MS) and its individual components are associated with the severity and progression of nonalcoholic fatty liver disease (NAFLD). We sought to evaluate the relationship between MS components and the risk of severe hepatic fibrosis in NAFLD patients discriminated by age. Methods: We considered 863 consecutive patients with biopsy-proven NAFLD, who had been fully evaluated for components of MS. Results: Multivariate logistic regression analysis showed that F3-F4 was associated with visceral obesity, IFG/diabetes, and low high-density lipoprotein (HDL) cholesterol, but not triglycerides >150 or arterial hypertension. A significant interaction was found betw…

Liver CirrhosisMaleGastroenterologyBody Mass Index0302 clinical medicineFibrosisNon-alcoholic Fatty Liver DiseaseRisk FactorsNonalcoholic fatty liver disease10. No inequalityDiabetesAge FactorsMiddle AgedMetabolic syndrome3. Good healthItalyLiver030220 oncology & carcinogenesisObesity Abdominal030211 gastroenterology & hepatologyFemaleWaist CircumferenceLipoproteins HDLAdultmedicine.medical_specialtyDiabetes Complications03 medical and health sciencesDiabetes mellitusInternal medicinemedicineHumansNonalcoholic fatty liver diseaseObesityAgedDiabetes; Metabolic syndrome; Nonalcoholic fatty liver disease; Obesity; HepatologyHepatologybusiness.industrynutritional and metabolic diseasesHepatologymedicine.diseaseObesityMiddle ageCross-Sectional StudiesLogistic ModelsdiabeteMultivariate AnalysisMetabolic syndromeInsulin ResistanceHepatic fibrosisbusiness
researchProduct

Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency

2015

Backgrounds and aims: Adrenal insufficiency (AI) has been reported in patients with stable cirrhosis. A lack of substrates has been suggested as a possible contributing pathogenic mechanism leading to glucocorticoid deficiency in these subjects. To better explore this hypothesis, we studied lipoproteins in cirrhotics with and without AI. Methods. A total of 81 cirrhotic patients and 30 normal volunteers were enrolled. The severity of liver disease was graded by Child-Pugh score. Total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), and apolipoprotein AI (Apo-AI) levels were evaluated. HDL subfractions were measured by gradient gel electrop…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosisSettore MED/09 - Medicina InternaHydrocortisoneCohort StudiesLiver diseasechemistry.chemical_compoundHDL cholesterolInternal medicineHDL cholesterol; adrenal insufficiency; cirrhosismedicineAdrenal insufficiencyHumansTriglyceridesAgedHydrocortisoneApolipoprotein AICirrhosiApolipoprotein A-ITriglyceridebusiness.industrycirrhosisCholesterol HDLCase-control studyGastroenterologyMiddle Agedmedicine.diseaseLipoproteins LDLEndocrinologychemistryCase-Control StudiesMultivariate AnalysisFemalelipids (amino acids peptides and proteins)Lipoproteins HDLbusinessadrenal insufficiencyGlucocorticoidmedicine.drugLipoprotein
researchProduct